A clinical update on chronic lymphocytic leukemia. I. Diagnosis and prognosis.

[1]  S. Thibodeau,et al.  Demonstration of clonality, by X-linked DNA analysis, in chronic natural killer cell lymphocytosis and successful therapy with oral cyclophosphamide. , 1992, Leukemia.

[2]  E. Montserrat,et al.  Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. , 1991, Blood.

[3]  S. Molica.  Progression and survival studies in early chronic lymphocytic leukemia. , 1991, Blood.

[4]  P. Wiernik,et al.  Neoplastic Diseases of the Blood , 1991 .

[5]  M. Oken,et al.  Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Oscier,et al.  Correlation of chromosome abnormalities with laboratory features and clinical course in B‐cell chronic lymphocytic leukaemia , 1990, British journal of haematology.

[7]  S. Knuutila,et al.  Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. , 1990, The New England journal of medicine.

[8]  D. Oscier,et al.  Prognostic factors in stage AO B‐cell chronic lymphocytic leukaemia , 1990, British journal of haematology.

[9]  C. Scott,et al.  Chronic B-Cell Malignancies in Patients with Lymphocytosis. , 1990, Leukemia and Lymphoma.

[10]  B. Grosbois,et al.  Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of a randomized clinical trial on 612 patients. The French Cooperative Group on Chronic Lymphocytic Leukemia. , 1990, Blood.

[11]  C. Geisler,et al.  B‐cell chronic lymphocytic leukaemia: Clonal chromosome abnormalities and prognosis in 89 cases , 1989, European journal of haematology.

[12]  A. Tefferi,et al.  Correlation of clinical outcome with the degree of surface immunoglobulin (sIg) expression in B-cell chronic lymphocytic leukemia. , 1989, American journal of clinical pathology.

[13]  D. Catovsky,et al.  Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival , 1989, British journal of haematology.

[14]  M. Grever,et al.  Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group , 1988, American journal of hematology.

[15]  E. Montserrat,et al.  Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages. , 1988, Nouvelle revue francaise d'hematologie.

[16]  S. Molica,et al.  Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia , 1987, Cancer.

[17]  C. Kittas,et al.  B‐chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients experience from a single hematology unit , 1987, Cancer.

[18]  F. Garver,et al.  An antigen common to chronic lymphocytic and hairy cell leukemia cells not shared by normal lymphocytes or by other leukemic cells. , 1986, Blood.

[19]  Ciril Rozman,et al.  Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance , 1986, British journal of haematology.

[20]  S. Larsen,et al.  The bone marrow histological pattern has independent prognostic value in early stage chronic lymphocytic leukaemia , 1986, British journal of haematology.

[21]  D. Catovsky,et al.  Prognostic significance of chromosome abnormalities in chronic lymphocytic leukaemia , 1984, British journal of haematology.

[22]  E. Montserrat,et al.  Bone marrow histologic pattern--the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. , 1984, Blood.

[23]  J. Minowada,et al.  Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  E. Henderson,et al.  Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia. , 1984, The New England journal of medicine.

[25]  H. Thaler,et al.  Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone). , 1982, Blood.

[26]  E. Montserrat,et al.  Chronic Lymphocytic Leukaemia: Proposals for a Revised Prognostic Staging System , 1981 .

[27]  K. Rai,et al.  Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. , 1977, Blood.

[28]  E. Cronkite,et al.  Clinical staging of chronic lymphocytic leukemia. , 1975, Blood.

[29]  D. Galton,et al.  The pathogenesis of chronic lymphocytic leukemia. , 1966, Canadian Medical Association journal.